US FDA investigating potential link between CAR-T-cell therapy and lymphomas, with 33 reported cases among 30,000 patients and boxed warning requirement on therapies.
Unclear if cancer development directly linked to CAR-T-cell manipulations or other therapies received, unresolved questions highlight need for more research and understanding.
Researchers like Bruce Levine emphasize the urgency to gather more information and data quickly to better comprehend and address the risks associated with the therapy.
[
add
]
[
|
|
...
]